SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: peter michaelson who wrote (240)9/9/2000 6:15:19 PM
From: scaram(o)uche  Read Replies (1) of 1833
 
I'll punt and wait for Bob or Peter to arrive. I did find this, but I can't find a web-based translator for it. I stuck it into this translator, but the language wasn't recognized......

world.altavista.com

Deferred tax assets of approximately $19,582,000 and $7,204,000 at
December 31, 1998 and 1997, respectively, relate principally to tax net
operating loss carryforwards of $21,459,000 and $13,933,000 and research
credit carryforwards of $2,111,000 and $1,212,000 at December 31, 1998
and 1997, respectively and also to the current litigation reserve
pending of $18.5 million. An offsetting valuation allowance has been
established for the full amount of the deferred tax assets to reduce such
assets to zero, as a result of the significant uncertainty regarding
their ultimate realization. The aggregate valuation allowance increased
$12,378,000 and $3,417,000 during the periods ended December 31, 1998 and
1997, respectively.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext